These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9916669)

  • 21. Barbiturate jaundice. Report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital.
    Pagliaro L; Campesi G; Aguglia F
    Gastroenterology; 1969 May; 56(5):938-43. PubMed ID: 4238546
    [No Abstract]   [Full Text] [Related]  

  • 22. Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report.
    Bizouard P; Vandel S; Kantelip JP
    Therapie; 2001; 56(4):443-5. PubMed ID: 11677871
    [No Abstract]   [Full Text] [Related]  

  • 23. Paroxetine in the treatment of generalised anxiety disorder.
    Snyderman SH; Rynn MA; Bellew K; Rickels K
    Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Paroxetine (paxil): use in clinical practice].
    Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
    Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.
    John AP; Koloth R
    Aust N Z J Psychiatry; 2007 Feb; 41(2):192-3. PubMed ID: 17484083
    [No Abstract]   [Full Text] [Related]  

  • 27. SSRIs and ejaculation.
    Robbins A
    J Clin Psychopharmacol; 2003 Feb; 23(1):108; author reply 108-9. PubMed ID: 12544388
    [No Abstract]   [Full Text] [Related]  

  • 28. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.
    Polimeni G; Grugno R; Cordici F; Vitetta A; Caputi AP; Bramanti P
    J Clin Psychopharmacol; 2008 Oct; 28(5):589-91. PubMed ID: 18794668
    [No Abstract]   [Full Text] [Related]  

  • 30. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome after addition of paroxetine to olanzapine.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Pappa DA; Katritsis DE; Christodoulou GN
    J Clin Psychopharmacol; 2003 Dec; 23(6):671-2. PubMed ID: 14624202
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine].
    Skjelbo EF; Brøsen K
    Ugeskr Laeger; 1998 Sep; 160(39):5665-6. PubMed ID: 9771062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of SSRI-induced hyponatremia.
    Corrington KA; Gatlin CC; Fields KB
    J Am Board Fam Pract; 2002; 15(1):63-5. PubMed ID: 11841140
    [No Abstract]   [Full Text] [Related]  

  • 34. Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation.
    Uguz F
    Breastfeed Med; 2019 Mar; 14(2):131-132. PubMed ID: 30489153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Bakker A
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
    [No Abstract]   [Full Text] [Related]  

  • 37. Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine.
    Onalan O; Cumurcu BE; Bekar L
    Mayo Clin Proc; 2008 May; 83(5):595-9. PubMed ID: 18452693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexual dysfunction associated with serotonin specific reuptake inhibitors.
    Herrán A; Palacios-Araus L; Vázquez-Barquero JL; Díez-Manrique JF
    J Clin Psychopharmacol; 1997 Feb; 17(1):67-8. PubMed ID: 9004071
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination of serotonergic agents resulted in severe adverse effects].
    Jägestedt M; von Bahr C
    Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.